Boys | Girls | ||||||||
n | Adjusted R2 | β | SE | p Value | Adjusted R2 | β | SE | p Value | |
Dependent variables | Neck circumference | ||||||||
VO2 max (mL/kg/min) | 2146 | 0.231 | −1.173 | 0.062 | <0.001 | 0.018 | −0.467 | 0.081 | <0.001 |
SBP (mm Hg) | 2191 | 0.353 | 2.526 | 0.155 | <0.001 | 0.353 | 2.526 | 0.155 | <0.001 |
DBP (mm Hg) | 2191 | 0.113 | 1.195 | 0.111 | <0.001 | 0.089 | 1.216 | 0.133 | <0.001 |
TC/HDL-c (mg/dL) | 514 | 0.098 | 0.098 | 0.015 | <0.001 | 0.048 | 0.073 | 0.019 | <0.001 |
LDL-c (mg/dL) | 513 | 0.013 | 1.377 | 0.663 | 0.039 | 0.007 | −0.844 | 0.516 | 0.103 |
Triglycerides (mg/dL) | 514 | 0.038 | 1.669 | 0.490 | <0.001 | 0.042 | 1.799 | 0.553 | <0.001 |
HOMA score | 342 | 0.169 | 0.256 | 0.043 | <0.001 | 0.073 | 0.604 | 0.160 | <0.001 |
CRP (mg/dL) | 315 | 0.055 | 0.351 | 0.094 | <0.001 | <0.001 | −0.092 | 0.094 | 0.328 |
C-3 protein (mg/dL) | 514 | 0.035 | 3.164 | 0.728 | <0.001 | 0.026 | 1.630 | 0.557 | 0.004 |
C-4 protein (mg/dL) | 514 | 0.037 | 0.478 | 0.129 | <0.001 | 0.024 | 0.539 | 0.189 | 0.005 |
IL-6 (pg/mL) | 502 | <0.001 | −0.200 | 0.527 | 0.705 | 0.003 | −1.552 | 1.139 | 0.174 |
Leptin (ng/mL) | 499 | 0.060 | 713.142 | 155.007 | <0.001 | 0.179 | 1927.779 | 252.179 | <0.001 |
Adiponectin (µg/mL) | 506 | 0.049 | −0.357 | 0.084 | <0.001 | 0.036 | −0.463 | 0.138 | <0.001 |
TNF-α (pg/mL) | 478 | <0.001 | 1.058 | 1.182 | 0.539 | 0.016 | −2.052 | 3.976 | 0.413 |
Visfatin (ng/mL) | 324 | 0.107 | −0.100 | 0.025 | <0.001 | 0.012 | −0.046 | 0.030 | 0.124 |
Cardiovascular risk score | 315 | 0.130 | 0.287 | 0.103 | <0.001 | 0.207 | 0.834 | 0.248 | <0.001 |
Associations with a p value of <0.05 are marked as bold.
All analyses were controlled for age and Tanner stage.
β, estimated unstandardized regression coefficient; SE, standard error.
VO2max, maximum oxygen consumption; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC/HDL-c, total cholesterol/ high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TG, triglycerides; HOMA, homeostasis model assessment; IL-6, interleukin 6; TNF-α, tumour necrosis factor alpha.